I have been wanting to write for a while about the demise of Xigris, but work and other commitments have stalled my progress. But it is time.Here is my disclosure: I have received research funding from BioCritica, a daughter company of Eli Lilly, the manufacturer of Xigris. I also happen to know well and hold in high esteem the depth of knowledge and integrity of several colleagues who worked on Xigris internally at Lilly.But on to the story. Xigris...
Tuesday, 22 November 2011
Lessons from Xigris
November 22, 2011
bundles, methods, mortality, NNT, public health, quality, sepsis, septic shock, Surviving Sepsis Campaign, VERICC, Xigris
No comments
Monday, 21 November 2011
Massachusetts' unwinnable gamble
It is ironic how, just a few days following the startling (?) confirmation by the Robert Wood Johnson Foundation-funded research that an ounce of prevention is indeed worth a pound of cure, the Massachusetts legislature with reckless abandon ushered in yet another mechanism for the erosion of public health: legalized gambling. Really, I have nothing against a little gambling. The issue is that this legislative move does not just open the door to...